The young, the healthy and those earning more stand to get greater compensation if they suffer any untoward incident during a clinical trial. The Drug Controller General of India on Friday came out with new guidelines for determing the quantum of financial compensation to be paid in case of a clinical-trial-related injury or death.

The experts decided to take into account parameters like the age of the deceased, income of the deceased, seriousness and severity of the disease that the subject was suffering at the time of his/her participation in the trial and the percentage of permanent disability to calculate the compensation to be paid to family members of the deceased.